Dr Belal Chami is a lecturer and a career biomedical researcher at the Charles Perkins Centre and Westmead Hospital; his research area examines reactive oxygen species and inflammation in the setting of chronic inflammatory aetiologies. Chami has held competitive fellowships from MAWA and has obtained industry grants (Pharmaxis, via a Commonwealth Innovation), as well as competitive funding from various agencies (Sydney West-Translational Cancer Research Centre, Australian Dental Research Foundation and Sydney Dental School Research Committee) and, more recently, an international grant from the Crohns and Colitis Foundation. Dr Belal Chami has a proven track record in the field of biomedical research, having published 24 peer-reviewed papers, two book chapters, four review articles, being an invited guest editorial and having an international patent. Currently, Dr Chami heads a small lab research unit at the Charles Perkins Centre in Molecular Biomedicine with a focus on identifying biomarkers of inflammation in patient-derived tissues with inflammatory bowel disease. Dr Belal Chami is interested in exploring the relationship between oxidative stress/damage in the evolution of tissue damage in acute and chronic inflammatory conditions, namely, inflammatory bowel disease (IBD). Dr Belal Chami is interested in understanding how peroxidase systems, most notably myeloperoxidase (MPO), contribute to host-tissue injury during chronic inflammatory aetiologies.